Third party CMV viral specific T-cells for refractory CMV viremia and disease after hematopoietic transplant.

The Journal of clinical investigation(2023)

引用 2|浏览41
暂无评分
摘要
This study was supported by funding from the National Institute of Health (P01 CA23766, R21 CA162002 and P30 CA008748), the Aubrey Fund, Claire Tow Foundation, Major Family Foundation, "Rick" Eisemann Pediatric Research Fund, Banbury Foundation, Edith Robertson Foundation, and Larry Smead Foundation.
更多
查看译文
关键词
Immunotherapy,Infectious disease,Stem cell transplantation,T cells,Transplantation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要